IP Library Granted Patent US 11,141,273
Granted Patent B2
US 11,141,273 · App. 16/297,075 · Granted Oct 12, 2021

Paravalvular leak occlusion device for self-expanding heart valves

Inventors: Gregory James Dakin (Minneapolis, MN); Peter Nicholas Braido (Wyoming, MN)
Assignee: St. Jude Medical, Cardiology Division, Inc.
A61F2/246A61F2/2418A61F2/2412A61F2250/0003A61F2250/0069
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,141,273
App. No.
16/297,075
Granted
Oct 12, 2021
Kind
B2
Abstract

An occluder device for occluding a gap between a medical device and adjacent body tissue includes a conformable body having a hollow interior, a leading end and a trailing end; and a port disposed at the trailing end of the body and in fluid communication with the interior of the body.

Claims (26)

1. A system for replacing native valve function, the system comprising:

a prosthetic heart valve having a collapsible and expandable stent, the stent having a plurality of sections, and a valve assembly disposed in the stent;

an occluder having a leading end and a trailing end, the trailing end disposed adjacent an inflow end of the stent, the occluder configured to be disposed between the prosthetic heart valve and adjacent body tissue for occluding a gap between the prosthetic heart valve and the adjacent body tissue,

wherein the occluder includes securing features disposed on and projecting from the occluder, the securing features configured to couple the occluder to the prosthetic heart valve and the adjacent body tissue, and

wherein the occluder comprises a fillable chamber with a delivery, pre-deployment configuration and a final, post-deployment configuration, the occluder in both the pre-deployment and post-deployment configurations including a port disposed at the trailing end and in fluid communication with the fillable chamber.

2. The system of claim 1 , wherein the occluder longitudinally extends in a lengthwise direction toward an outflow end of the stent.

3. The system of claim 1 , further comprising a source of gas in fluid communication with the port.

4. The system of claim 1 , further comprising a source of polymeric filler in fluid communication with the port.

5. The system of claim 1 , wherein the fillable chamber of the occluder has an outer coating configured to prevent leakage of a liquid or a gas.

6. The system of claim 1 , wherein the plurality of sections of the stent includes an annulus section, a transition section, and an aortic section.

7. The system of claim 1 , wherein the occluder includes at least one of a metallic mesh or a shape-memory material.

8. The system of claim 1 , wherein the securing features includes a plurality of hooks disposed on the occluder and the prosthetic valve includes a cuff having a plurality of perforations, the hooks of the occluder being coupleable to the perforations of the cuff.

9. The system of claim 1 , wherein the securing features on the occluder includes a first magnetic element configured to attract to a second magnetic element disposed on the prosthetic heart valve to secure the occluder to the prosthetic heart valve.

10. The system of claim 1 , wherein the securing features of the occluder includes barbs shaped having a first shape to prevent the occluder from migrating toward the ventricle and barbs having an opposite second shape to prevent the occluder from migrating toward the aorta.

11. A system for replacing native valve function, the system comprising:

a prosthetic heart valve having a collapsible and expandable stent, the stent having a plurality of sections, and a valve assembly disposed in the stent;

an occluder having a leading end and a trailing end disposed adjacent an inflow end of the stent, the occluder including a port disposed at the trailing end, the occluder configured to be disposed between the prosthetic heart valve and adjacent body tissue for occluding a gap between the prosthetic heart valve and the adjacent body tissue,

wherein the occluder includes securing features disposed on and projecting from the occluder, the securing features configured to couple the occluder to the prosthetic heart valve and the adjacent body tissue.

12. The system of claim 11 , wherein the occluder longitudinally extends in a lengthwise direction toward an outflow end of the stent.

13. The system of claim 11 , wherein the occluder comprises a fillable chamber with a delivery, pre-deployment configuration and a final, post-deployment configuration, the occluder in both the pre-deployment and post-deployment configurations including the port in fluid communication with the fillable chamber.

14. The system of claim 11 , further comprising a source of gas in fluid communication with the port.

15. The system of claim 11 , further comprising a source of polymeric filler in fluid communication with the port.

16. The system of claim 11 , wherein the plurality of sections of the stent includes an annulus section, a transition section, and an aortic section.

17. The system of claim 11 , wherein the securing features includes a plurality of hooks disposed on the occluder and the prosthetic valve includes a cuff having a plurality of perforations, the hooks of the occluder being coupleable to the perforations of the cuff.

18. The system of claim 11 , wherein the securing features on the occluder includes a first magnetic element configured to attract to a second magnetic element disposed on the prosthetic heart valve to secure the occluder to the prosthetic heart valve.

19. The system of claim 11 , wherein the securing features of the occluder includes barbs shaped having a first shape to prevent the occluder from migrating toward the ventricle and barbs having an opposite second shape to prevent the occluder from migrating toward the aorta.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2021
From: AGA MEDICAL CORPORATION
To: ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC.
Reel/Frame 057214/0022 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2019
From: DAKIN, GREGORY JAMES; BRAIDO, PETER NICHOLAS
To: AGA MEDICAL CORPORATION
Reel/Frame 049460/0899 →
Continuity (3)
Continuation 14096427 · Dec 4, 2013
Continuation In Part 13797513 · Mar 12, 2013
Related Publication 20190201190A1 · Jul 4, 2019
Cited By (13)
US 1,057,152 US 12,186,184 US 12,239,532 US 12,285,334 US 12,295,840 US 12,295,869 US 12,329,641 US 12,440,329 US 12,472,061 US 12,544,219 US 12,685,634 US 12,690,961 US 12,690,965